Nutrition+ Study: High-Protein Formula for Type 2 Diabetes Patients on Incretin Mimetics
This study is looking at how a special high-protein diabetes formula (HP-DSF shakes from Abbott Nutrition) affects muscle mass in people with Type 2 Diabetes. You might be able to join if you are 18-75 years old, have Type 2 Diabetes, and are about to start a new treatment with an incretin mimetic drug like semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), or dulaglutide (Trulicity®). The main goal is to see if the high-protein formula helps you keep or gain lean muscle mass over three and six months. The current status of this study is unclear, but it plans to enroll 60 participants.
- Study design
- This is a randomized clinical study, meaning participants will be assigned by chance to different groups. It aims to enroll 60 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main results will be analyzed at three months and six months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Osama Hamdy, MD, PhD · PRINCIPAL_INVESTIGATOR · Joslin Diabetes Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in lean muscle mass from baselineEndpoints will be analyzed at three months and six months.